Over the recent years, the global Micro-Invasive Glaucoma Surgery industry has been growing rapidly as the global sales of iStent device by Glaukos which was the only commercially available device in United States has witnessed rapid growth post its FDA approval in 2012. Globally, the growth in micro-invasive glaucoma surgery device market is driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population. 更多
